Lung cancer is one of the leading cancers all over the world. Positron emission tomography (PET) using 18F fluorodeoxyglucose (18F FDG) is useful for staging of the disease and decide the appropriate management. 3'-deoxy-3'-18 F-fluorothymidine (18F FLT) is a tracer being extensively evaluated currently and is said to represent tumor proliferation. Common sites of metastases from lung cancer include adrenal glands, bone, and brain. Muscle metastasis and cardiac metastasis are uncommon findings. We report a case of squamous cell carcinoma of the lung with metastases to multiple skeletal muscles and myocardium detected with both FDG and FLT PET/computed tomography (CT).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020800PMC
http://dx.doi.org/10.4103/1450-1147.167607DOI Listing

Publication Analysis

Top Keywords

cardiac metastasis
8
squamous cell
8
cell carcinoma
8
carcinoma lung
8
detected fdg
8
fdg flt
8
lung cancer
8
disseminated skeletal
4
skeletal muscle
4
muscle cardiac
4

Similar Publications

Article Synopsis
  • Mammary carcinoma consists of different cell types with varying abilities to spread, and a specific type of cell (4T1) was identified as highly metastatic, influenced by TGF-β and BMP-1.
  • Researchers found that inhibiting BMP-1 not only reduced cancer cell growth but also improved the effectiveness of the chemotherapy drug doxorubicin.
  • This study highlights the potential of targeting BMP-1 as a promising therapeutic strategy for treating aggressive metastatic breast cancer.
View Article and Find Full Text PDF

Cardiac metastases are the most frequent cardiac tumors. They can cause dysrhythmia, myocardial dysfunction, pericardial effusion, and heart failure. In decreasing order, the major primary malignancies associated with cardiac metastases are pleural mesothelioma, lung adenocarcinoma, undifferentiated carcinomas, lung squamous cell carcinoma, and breast carcinoma.

View Article and Find Full Text PDF

Cardiovascular Disease and Cancer: A Dangerous Liaison.

Arterioscler Thromb Vasc Biol

January 2025

Cardiovascular Research Center, New York University Langone Health, New York University Grossman School of Medicine. (A.A.C.N., J.M.D., K.J.M.).

The field of cardio-oncology has traditionally focused on the impact of cancer and its therapies on cardiovascular health. Mounting clinical and preclinical evidence, however, indicates that the reverse may also be true: cardiovascular disease can itself influence tumor growth and metastasis. Numerous epidemiological studies have reported that individuals with prevalent cardiovascular disease have an increased incidence of cancer.

View Article and Find Full Text PDF

A 65-year-old woman with a history of ductal mammary carcinoma and recent autonomic dysfunction underwent a Rb-82 chloride (RbCl) cardiac PET/CT scan that showed no ischemia or scarring, but significantly reduced myocardial flow reserve (MFR) (global: 1.5) and a CAC-Score of 0. The patient's chemotherapy history (paclitaxel, carboplatin, epirubicin, pembrolizumab 2 years before) with elevated Troponin T and NT-pro-BNP levels at that time, and now reduced MFR with 0 CAC suggests cancer-therapy-related cardiotoxicity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!